Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Ionic compound, anti-static pressure-sensitive adhesive and polarizer comprising the same
System, method and program product for guiding correction of semantic errors in code using collaboration records
Fabrication method of packaging substrate having through-holed interposer embedded therein
Carbonate and carbamate modified forms of glucocorticoids in combination with .beta..sub.2 adrenergic agonists
Processing biomass
Perception-based artifact quantification for volume rendering
Low power voltage controlled oscillator (VCO)
  Randomly Featured Patents
Molten salt stripping of electrode coatings
Programmable logic device input/output circuit configurable as reference voltage input circuit
Swivel connector for electrical appliances
Electronic exchange having a conference telephone communication function and conference telephone communication method
Serving tray with LED light
Desensitizer compositions
Vehicle cargo area divider system
Furnace flue dust processing method
Automatic web splice control system